1036027-56-1 Usage
Heterocyclic compound
The compound has a pyrrolopyridine core structure, which is a combination of a pyrrole and a pyridine ring.
Sulfonyl group
A sulfonyl group (-SO2-) is attached to the 1-position of the pyrrolopyridine ring. This group is known for its ability to improve solubility and metabolic stability of drug molecules.
Trifluoromethyl group
A trifluoromethyl group (-CF3) is attached to the 5-position of the pyrrolopyridine ring. This group is known for its ability to improve binding affinity to biological targets and can also affect the physicochemical properties of the compound.
Potential pharmaceutical applications
The compound has potential applications in pharmaceutical research and development, particularly in the synthesis of biologically active molecules.
Building block for drug synthesis
The compound may also have potential use as a building block for the synthesis of novel drug candidates.
Check Digit Verification of cas no
The CAS Registry Mumber 1036027-56-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,6,0,2 and 7 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1036027-56:
(9*1)+(8*0)+(7*3)+(6*6)+(5*0)+(4*2)+(3*7)+(2*5)+(1*6)=111
111 % 10 = 1
So 1036027-56-1 is a valid CAS Registry Number.
1036027-56-1Relevant articles and documents
5-CYAN0-4- (PYRROLO [2, 3B] PYRIDINE-3-YL) -PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS
-
Page/Page column 59; 60, (2008/12/07)
The present invention relates to compounds useful as inhibitors of protein kinase. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders. The invention also provides processes for preparing compounds of the inventions.
